Avecho doses first patient in phase III sleep trial by Martin Lane May 16, 2024July 16, 2024 Avecho has dosed the first patient in a phase III clinical trial testing an oral CBD […]
CBD stability boost for Avecho ahead of insomnia clinical trial by Steve Jones June 23, 2023April 30, 2024
Avecho turns to new investors to raise funds for CBD clinical trial by Steve Jones May 9, 2023April 30, 2024
Financial results: Elixinol; Emyria; Epsilon; Avecho; Creso Pharma; AusCann; MGC Pharma; Botanix; Zelira by Martin Lane and Steve Jones March 1, 2023April 30, 2024
Lambert researchers to study Avecho CBD soft gel for novel indications by Steve Jones February 22, 2023April 30, 2024
Company news: Avecho; Levin Health; Cannatrek; Releaf Group; Bod Science by Martin Lane and Steve Jones December 22, 2022April 29, 2024
Avecho chief warns of placebo dangers as firms roll out CBD clinical trials by Steve Jones October 20, 2022April 29, 2024
Avecho study shows TPM formulation has ‘superior absorption to Epidyolex’ by Steve Jones September 19, 2022April 29, 2024
Financial results: Avecho; AusCann; Zelira; Elixinol; Cann Group; Incannex; Creso Pharma; Medlab; Rua Bioscience by Steve Jones and Martin Lane September 1, 2022April 29, 2024
